Aetna provides $6.1 million to support services for Children with Serious Emotional Disorders PressReach · Dec 9, 2022
Quest Diagnostics and Northern Light Health Form Strategic Laboratory Collaboration to Improve Access to Affordable Diagnostic Services in Maine PressReach · Dec 9, 2022
Gilead Sciences: U.S. Military Veteran Battles Lymphoma With Car T-Cell Therapy: Marcus' Story PressReach · Dec 9, 2022
FDA Accepts Biogen Biologics License Application for BIIB800, A Biosimilar Candidate Referencing ACTEMRA® (tocilizumab) PressReach · Dec 9, 2022
Multi-Center Research Study Illustrates How OGM Can Potentially Result in More Patients Qualifying for Treatments in Leukemia PressReach · Dec 9, 2022
Amarin Announces VAZKEPA® (icosapent ethyl) Receives Regulatory Approval in Switzerland PressReach · Dec 8, 2022
Atossa Therapeutics Announces the Appointment of Eric Van Zanten as Vice President, Investor and Public Relations PressReach · Dec 8, 2022